Reaching hard-to-reach individuals: Nonselective versus targeted outbreak response vaccination for measles

American Journal of Epidemiology

Volumn 179, Issue 2, 2014, Pages 245-251

  Minetti, Andrea ^b   Hurtado, Northan ^c   Grais, Rebecca F ^b   Ferrari, Matthew ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b EPICENTRE   (France)

^c MÉDECINS SANS FRONTIÈRES   (Switzerland)

Author keywords

hard to reach individuals; Malawi; measles; outbreak response; vaccination

Indexed keywords

MEASLES VACCINE;

DISEASE SPREAD; HETEROGENEITY; MEASLES; PUBLIC HEALTH; SPATIOTEMPORAL ANALYSIS; VACCINATION;

ARTICLE; BASIC REPRODUCTION NUMBER; FEASIBILITY STUDY; HEALTH CARE COST; HUMAN; IMMUNE STATUS; IMMUNITY; MEASLES; MEASLES VACCINATION; SECONDARY INFECTION; SUSCEPTIBLE POPULATION;

HARD-TO-REACH INDIVIDUALS; MALAWI; MEASLES; OUTBREAK RESPONSE; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASE CONTROL; DISEASE OUTBREAKS; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MALAWI; MEASLES; MEASLES VACCINE; MODELS, THEORETICAL; VACCINATION;

MALAWI;

EID: 84891510505     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwt236     Document Type: Article

References (16)

1. World Health Organization. Response to Measles Outbreaks in Measles Mortality Reduction Settings. Geneva, Switzerland: World Health Organization Press; 2009.
2. Grais RF, Conlan AJK, Ferrari MJ, et al. Time is of the essence: Exploring a measles outbreak response vaccination in Niamey, Niger. J R Soc Interface. 2008;5(18):67-74.
3. Toikilik S, Tuges G, Lagani J, et al. Are hard-to-reach populations being reachedwith immunization services? Findings from the 2005 Papua New Guinea national immunization coverage survey. Vaccine. 2010;28(29):4673-4679.
4. Esteghamati A, Gouya MM, Zahraei SM, et al. Progress in measles and rubella elimination in Iran. Pediatr Infect Dis J.2007;26(12):1137-1141.
5. Stein-Zamir C, Zentner G, Abramson N, et al. Measles outbreaks affecting children in Jewish ultra-orthodox communities in Jerusalem. Epidemiol Infect. 2008; 136(2):207-214.
6. Minetti A, Kagoli M, Katsulukuta A, et al. Lessons and challenges for measles control from an unexpected large outbreak in Malawi. Emerg Infect Dis. 2013;19(2):202-209.
7. Greenwood BM, Yule GU. The statistics of anti-typhoid and anti-cholera inoculations, and the interpretation of such statistics in general. Proc R Soc Med. 1915;8:113-194.
8. Haber M, Orenstein WA, Halloran ME, et al. The effect of disease prior to an outbreak on estimates of vaccine efficacy following the outbreak. AmJ Epidemiol. 1995;141(10):980-990.
9. Halloran ME, Haber M, Longini IM. Interpretation and estimation of vaccine efficacy under heterogeneity. Am J Epidemiol. 1992;136:328-343.
10. Wearing HJ, Rohani P, Keeling MJ. Appropriate models for the management of infectious diseases. PLoS Med. 2005; 2(7):621-627.
11. Keeling MJ, Rohani P. Modeling Infectious Diseases in Humans and Animals. Princeton, NJ: Princeton Universtiy Press; 2007.
12. Okwaraji YB, Mulholland K, Schellenberg J, et al. The association between travel time to health facilities and childhood vaccine coverage in rural Ethiopia. A community based cross sectional study. BMC Public Health. 2012;12:476-484.
13. Zimicki S, Hornik RC, Verzosa CC, et al. Improving vaccination coverage in urban areas through a heatlh communication campaign - the 1990 Philippine experience. Bull World Health Organ. 1994;72(3):409-422.
14. Rosenthal J, Rodewald L, McCauley M, et al. Immunization coverage levels among 19- to 35-month-old children in 4 diverse, medically underserved areas of the United States. Pediatrics. 2004;113(4):E296-E302.
15. Muscat M. Who gets measles in Europe? J Infect Dis. 2011; 204(suppl 1):S353-S365.
16. Minetti A, Bopp C, Fermon F, et al. Measles outbreak response immunization is context-specific. Insight from the recent experience of Médecins Sans Frontières. (In press).